- Approval Id
- 53fb96cad39a85dd
- Drug Approval Philippines Name
- Pneumocon-13
- Product Name
- Pneumocon-13
- Registration Number
- BR-1451
- Brand Name
- Pneumocon-13
- Generic Name
- Pneumococcal Polysaccharide Conjugate Vaccine, 13-
Valent (Adsorbed)
- Dosage Form
- Suspension for Injection (IM)
- Dosage Strength
- Each dose (0.5 mL) contains the capsular polysaccharide of the following Streptococcus pneumoniae serotypes:
Pneumococcal Polysaccharide Serotype 6B
Pneumococcal Polysaccharide Serotype 18C
Pneumococcal Polysaccharide Serotype 4, 23F
Pneumococcal Polysaccharide Serotype 7F
Pneumococcal Polysaccharide Serotype 14, 19F
Pneumococcal Polysaccharide Serotype 1, 19A
6.0 με 3.25 μg
3.0 με
2.85 με
- 2.75 με
2.6 με
Pneumococcal Polysaccharide Serotype 3, 5, 6A, 9V Conjugated to Tetanus Toxoid carrier protein
2.5 με 41-150 με
- Manufacturer
- Yuxi Walvax Biotechnology Co., Ltd.
- Importer
- 2 World Traders Inc.
- Distributor
- 2 World Traders Inc.
- Company Detail Path
- /organization/yuxi-walvax-biotechnology-co-ltd
- Issuance Date
- 03 November 2023
- Expiry Date
- 03 November 2028
- Classification
- Prescription Drug (RX)
